Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 May 24;8(6):ytae265.
doi: 10.1093/ehjcr/ytae265. eCollection 2024 Jun.

Early structural valve deterioration of balloon expandable transcatheter aortic valve leaflets due to intrinsic and extrinsic nodular calcifications in a haemodialysis patient: a case report

Affiliations
Case Reports

Early structural valve deterioration of balloon expandable transcatheter aortic valve leaflets due to intrinsic and extrinsic nodular calcifications in a haemodialysis patient: a case report

Kyohei Onishi et al. Eur Heart J Case Rep. .

Abstract

Background: Several reports have shown that transcatheter aortic valves are comparable in durability to surgical aortic valves. However, early structural valve deterioration (SVD) is rarely reported to occur, especially in haemodialysis patients.

Case summary: We present a case of rapidly progressive bioprosthetic aortic valve stenosis in a patient with end-stage renal disease secondary to diabetic nephropathy in an 83-year-old female admitted due to progressive dyspnoea and orthopnoea. A 23 mm sized SAPIEN3 bioprosthetic aortic valve showed normal function for the first year after transcatheter aortic valve implantation (TAVI), but then rapidly developed stenosis and required acute hospitalization for heart failure a year and a half after surgery. Emergent surgical aortic valve replacement with a 19 mm On-X valve (CryoLife, Kennesaw, GA, USA) was performed. Pathological examination of the explanted SAPIEN 3 valve demonstrated severely degenerated bioprosthetic pericardial leaflets with severe intrinsic and extrinsic nodular calcifications, which could limit the leaflet motion.

Discussion: There is a lack of reports on the long-term procedural outcomes of TAVI in haemodialysis patients. The development of SVD in patients undergoing dialysis is multifactorial and has yet to be fully elucidated. In the presented case, the removed TAVI valve had severe extrinsic calcified nodules alongside a fibrin thrombus. Considering these pathological findings, antithrombotic therapy to prevent fibrin thrombus from adhering to the TAVI valve may be important to avoid early SVD.

Keywords: Aortic valve stenosis; Case report; End-stage renal disease; Structural valve deterioration.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: K.M. is a clinical TAVI proctor of Edwards Lifesciences and Medtronic.

Figures

Figure 1
Figure 1
Contrast-enhanced computed tomography of the implanted TAVI valve (SAPIEN3) and representative histopathological images of the removed TAVI valve. Contrast-enhanced computed tomography showed severe calcification and thickening in all three prosthetic valve leaflets. (A) The removed TAVI valve showed adherence of nodular calcification in all tricuspids. (B and C) Gross images of explanted SAPIEN3 valve showing nodular calcification protruding to the aortic side of the leaflets. Low-power and high-power images of leaflet 1. (D and E) There is a severe leaflet extrinsic calcification containing calcific nodules and fibrin deposition. The surface of the leaflet is intact, and the border is easily recognized (red arrows). Low-power and high-power images of leaflet 3. (F and G) The leaflet is severely thickened and composed of intrinsic and extrinsic nodular calcifications. Yellow arrows indicate the separation of the leaflet collagen fibres, and intrinsic nodular calcification is observed between these fibres.

Similar articles

References

    1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597–1607. - PubMed
    1. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609–1620. - PubMed
    1. Mack MJ, Leon MB, Thourani VH, Pibarot P, Hahn RT, Genereux P, et al. Transcatheter aortic-valve replacement in low-risk patients at five years. N Engl J Med 2023;389:1949–1960. - PubMed
    1. Jørgensen TH, Thyregod HGH, Ihlemann N, Nissen H, Petursson P, Kjeldsen BJ, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J 2021;42:2912–2919. - PMC - PubMed
    1. Long Y-X, Liu Z-Z. Incidence and predictors of structural valve deterioration after transcatheter aortic valve replacement: a systematic review and meta-analysis. J Interv Cardiol 2020;2020:4075792. - PMC - PubMed

Publication types

LinkOut - more resources